Jeff Kravitz/MTV VMAs 2020/Getty Images for MTV(LOS ANGELES) — ABC gave fans a two for one with the release of the latest promo for The Bachelorette.
Not only did the new clip give a glimpse into Clare Crawley’s upcoming season, it also shared a special BTS look at Keke Palmer recording a cover of Aretha Franklin’s “Respect.”
The video starts with a look back at the moment Crawley famously stood up to controversial Bachelor Juan Pablo during the memorable 18th season finale of The Bachelor.
“Never want my children having a father like you. I want respect,” she says just before Palmer’s rendition of the classic record begins to play.
Cut to the 39-year-old Bachelorette being showered in red rose petals while donning an elegant one-shoulder, floor length white gown. Between behind-the-scenes cuts of Palmer singing and dancing in the studio, clips of Crawley’s journey to find love appear on the screen, including a few of her locking lips with some lucky men.
The promo ends with Crawley playfully tossing a rose at the screen and smiling.
The Bachelorette returns Tuesday, October 13 at 8 p.m. ET on ABC.
ABC/Image Group LALuke Combs may be busy celebrating his six new CMA nominations — including his first for Entertainer of the Year — but that’s not all that’s going right for the man who’s currently topping the chart with “Lovin’ on You.”
September 1 also marked the North Carolina native’s one-month anniversary as a married man. He and longtime girlfriend Nicole Hocking tied the knot Saturday, August 1 in South Florida. So how is married life so far?
“It’s really great…” Luke told ABC Audio shortly after revealing the CMA noms on Good Morning America. “You know, we had to scale the wedding back the week before, change venues, and we actually didn’t pick the new venue until the day of the wedding.”
“So that was very interesting,” he continues. “There was a hurricane that looked like it was gonna come right over top of us, and at the, about the midnight hour there, it veered off to the end. So it ended up being perfect.”
Of course, there’s plenty of irony there, since Luke’s debut number-one single also happens to be called “Hurricane.”
In the end, Luke and Nicole enjoyed the upsides of a smaller ceremony.
“You know, it was smaller than we thought it would be, but it actually ended up, you know, being very manageable,” Luke reflects. “We got to have time with everyone that was there, and really enjoy the experience, and it was really special.”
“It’s something that I’ll cherish forever,” he adds.
Luke’s been teasing a romantic new song called “Forever After All,” which seems likely to be one of the new tracks on the expanded edition of his sophomore album.
What You See Is What You Get officially morphs into the deluxe What You See Ain’t Always What You Get on October 23.
BackyardProduction/iStockBy DR. HEATHER J. KAGAN, ABC News
(NEW YORK) — A deadly and potent opioid, nicknamed “ISO,” first hit the illicit drug market in the United States last year, and since August 2019 has taken the lives of at least 19 Americans, alarming addiction experts and prompting the Drug Enforcement Administration (DEA) to take action. Most of the deaths occurred in the Midwest, but ISO has also appeared in Canada and Europe.
ISO, short for Isotonitazene, “is a white or yellow powder [that] can be mixed with other substances,” said Dr. Roueen Rafeyan, the chief medical officer of the Gateway Foundation and an assistant professor of psychiatry at Northwestern University.
It’s a manufactured opioid, also called a “synthetic opioid,” similar to fentanyl but estimated to be even more potent, Rafeyan said. “In humans, it is probably 60 times stronger than morphine,” he added.
Since the dawn of the opioid epidemic, doctors and law enforcement officials have been grappling with wave after wave of new illicit substances. First, it was prescription painkillers. Then, when legislative change made those more difficult to traffic, the market turned to back to heroin, and later, the much more potent synthetic fentanyl.
Now, experts are concerned ISO might be the newest dangerous illegal opioid claiming lives. ISO has actually been around since the 1950s, but was not thought to be particularly threatening to human health — until now. It wasn’t until June of this year that the DEA first categorized it as a “schedule I” drug, meaning that it has “no currently accepted medical use and a high potential for abuse,” like heroin.
“[It] went under the radar,” said Dr. Harshal Kirane, the medical director of Wellbridge Addiction Treatment and Research.
It’s a derivative of etonitazene, a synthetic opioid first developed by pharmaceutical companies to treat pain, “but because it was really strong and had side effects, it really never gained medical use,” Rafeyan explained.
So why is ISO suddenly making a devastating appearance?
“One of the primary reasons ISO in particular has resurfaced now is that China banned fentanyl and all of its derivatives in 2019,” Kirane said. Because fentanyl was suddenly less available, manufacturers started producing other synthetic opioids to meet demand, he explained.
As the new kid on the block, ISO was also able “to evade regulation,” said Dr. Rebecca Trotzky-Sirr, an assistant professor of clinical emergency medicine at University of Southern California and the medical director of jail health services at LAC+USC. In other words, manufacturing, distributing, possessing and using ISO wasn’t illegal until the DEA made it a schedule I drug.
But regulation isn’t the only thing ISO has successfully evaded — it’s also been deceiving clinicians and people who struggle with substance use.
“Routine tests don’t pick it up,” and while 19 people were identified as dying of ISO overdoses, this is probably and underestimate, Rafeyan said. ISO was only linked to the 19 deaths after those bodies underwent autopsies.
Rafeyan described a particularly worrisome cluster of cases with devastating consequences due to ISO’s invisibility, where “known cocaine users [bought] cocaine, used it, overdosed and died, and they thought that it was maybe laced with fentanyl, but actually the cases are turning out to be ISO.”
Amid the coronavirus pandemic, Trotzky-Sirr said, “We see that people are going to different suppliers for their drugs and there’s just more unknown.”
Gateway Foundation, the largest non-profit substance use treatment center in the country, is actively developing a urine drug test that will detect ISO, aimed to provide results “within a couple of hours,” Rafeyan said.
He also emphasized the importance of rapid testing for getting people who have overdosed on ISO life-saving treatment. A medication called Naloxone, also known as Narcan, reverses the effects of opioids and can prevent death from an overdose if administered quickly.
“There are some reports that actually Narcan does work for [ISO], but you need higher doses and repeated dosing,” Rafeyan said. Testing for ISO will avoid situations where a patient who has used ISO is given a standard amount of Naloxone “and it doesn’t work, and the providers and doctors start thinking maybe this is something else,” missing an opportunity to save a life.
Naloxone comes in a nasal spray that can be administered by the public to anyone suspected of having overdosed on an opioid.
Overall, Kirane said, “ISO represents the next step in this ongoing cycle of more readily available, more potent synthetic opioids.”
So, what we can do about it? Getting the word out and making Naloxone accessible are two good places to start.
“It is really important for everyone to be aware of [ISO] — the health care community, as well as the general population,” Rafeyan said.
Trozky-Sirr said, “Naloxone should be made available and given to many of our community members and our patients.”
Heather J. Kagan, M.D., is an internal medicine resident physician at The Johns Hopkins Hospital and a contributor to the ABC News Medical Unit.
william87/iStockBy ALEX STONE and MINA KAJI, ABC News
(LOS ANGELES) — There is a mystery unfolding in Los Angeles. It wasn’t Buzz Lightyear or Robert Downey Jr. in “Iron Man,” but pilots landing at Los Angeles International Airport on Sunday evening reported seeing a man wearing a jetpack flying near their planes.
American Airlines flight 1997 from Philadelphia to L.A. was the first to report in.
“Tower, American 1997, we just passed a guy in a jetpack,” the American Airlines pilot radioed to air traffic control, according to recordings by LiveATC.net.
Air traffic controllers sounded stunned in response and asked the pilot for more details.
“American 1997… Okay…. Were they off to your left side or right side?” the controller asked.
The pilot said the man was flying with a jetpack at 3,000 feet and only about 300 yards away from the plane, Airbus A321.
Shortly after that, another pilot reported that he, too, saw a man in a jetpack flying near their plane.
“We just saw the guy passing by us in the jetpack,” the SkyWest pilot told controllers.
Other aircraft were then immediately warned to use caution because of a man wearing a jetpack flying in the path of planes.
“You don’t hear that every day,” a JetBlue pilot said. “Only in L.A.”
The Federal Aviation Administration (FAA) said that the report was turned over to the Los Angeles Police. Authorities have not found any man with a jetpack, and who or what came close to the plane remains a mystery. The FAA says an investigation is underway.
According to the FAA, reports of unmanned aircraft sightings from pilots, law enforcement personnel and the general public have increased dramatically over the past two years. The agency says it receives more than 100 such reports each month. If, in fact, the sighting was of a man with a jetpack, it would have been illegal for him to fly in commercial airline airspace or to fly alongside planes.
There are some human jetpacks in development that can reach altitudes of up to 12,000 feet with price tags of a half-million dollars.
“The size, weight of a person in a jet pack impacting an airplane at the exact wrong spot could potentially bring that airliner down,” ABC News Contributor and retired Marine Col. Steve Ganyard said. “This is why it’s so important for when these technologies come along — drones, jetpacks, taxis in the sky — that people need to fly them in a responsible way and not put the flying public in danger.”
An FBI spokesperson told ABC News “the FBI is aware of the reports by pilots on Sunday and is working to determine what occurred.”
ABC News’ Luke Barr and Amanda Maile contributed to this report.
(LOUISVILLE) — Kenneth Walker, the boyfriend of Breonna Taylor who allegedly opened fire at the officers who shot and killed her, announced Tuesday he’s suing the city of Louisville, its police and others, for immunity against his actions that night under Kentucky’s “stand your ground” law.
Walker, 27, and a licensed gun owner, was initially charged with attempted murder and assault following the March 13 incident, but those charges were dropped. Kentucky’s attorney general and the FBI are still investigating Taylor’s shooting, and Walker said the suit would prevent officials from re-arresting and charging him for any crime related to the incident.
“I was raised by a good family. I am a legal gun owner and I would never knowingly shoot at a police officer,” he said at a news conference.
On March 13, three undercover Louisville officers, Myles Cosgrove, Brett Hankison and Sgt. Jonathan Mattingly, executed a no-knock warrant at the apartment where Taylor and Walker were living. The officers contend that Taylor’s ex-boyfriend was shipping drugs to the address.
The couple was asleep when the officers allegedly tried to break down the door, which prompted Walker, a USPS worker, to get his licensed gun and fire at the door, according to the lawsuit.
The officers returned fire, killing Taylor, 26, an EMT, in her sleep and no drugs were found in the residence, police said. Mattingly was struck in the leg during the incident, according to police.
Taylor’s death gained national attention from activists all over the world who have called for the officers to be disciplined and criminally charged. As of Sept. 1, only one officer, Hankison, has been fired while Cosgrove and Mattingly have been placed on administrative duties.
Walker was immediately arrested after the shooting and released into home confinement less than two weeks later due to COVID concerns in the jail. In May, Jefferson County Commonwealth’s Attorney Tom Wine announced the charges against Walker were dropped as the FBI and state attorney general investigated the shooting.
Walker told reporters that the charges were made to silence him.
“I can no longer remain silent,” he said.
Walker’s attorney, Steve Romines, said his client has never been in trouble with the law before and had a legal right to own the gun. The suit contends the state’s “stand your ground” law “protects all Kentuckians who seek to protect themselves or loved ones in self-defense.”
The suit said that Walker asked, “Who is it?” three times to no response before the officers broke open the door.
“Kenny immediately reacted by firing a single shot to scare away the intruder or intruders,” the suit said.
Romines said he is still waiting to get a ballistics report, but questioned whether Mattingly was struck by his client’s bullet or friendly fire.
“It is still six months later and they’re still trying to figure out what happened in that apartment,” he said at the news conference.
In addition to preventing future prosecution, Walker is seeking damages in part for the gross negligence of the police “for the trauma, humiliation, indignity, physical pain, mental suffering, or mental anguish he suffered,” the suit said.
Jean Porter, a spokeswoman for Louisville Mayor Greg Fischer, said in a statement to ABC News that her office cannot comment on the specifics of the pending litigation.
“As the mayor has said, Breonna Taylor’s death was a tragedy, and justice, peace, and healing are what is needed for her, for her loved ones and for our community,” she said in a statement.
A spokesman for Wine’s office told ABC News that the office was not served as of Tuesday afternoon and could not comment on the suit. The Louisville Police Department could not be reached for comment.